Going forward, PTS and Appspace are providing ongoing service and support, with a team ensuring the systems perform at peak ...

GSK PLC closed 22.73% below its 52-week high of £18.24, which the company reached on May 16th.

GSK's Jemperli shows 100% efficacy in 49 MMRd rectal cancer patients, with complete disease elimination after six months' ...

With the American Association for Cancer Research’s annual conference now underway, oncology researchers can expect ...

A global biopharma is fighting malaria in endemic countries through partnerships that harness R&D, broaden access to ...

Some justices may be skeptical of a bid by GSK, Pfizer and others to overturn ruling allowing lawsuits to proceed over claims ...

British pharmaceutical giant GSK has not met required ethical and regulatory standards in the marketing and prescription ...

GSK has been found guilty of bringing discredit on the pharma industry after a complainan | GSK has been found guilty of ...

We recently published a list of the 11 Best Undervalued UK Stocks to Buy Right Now. In this article, we are going to take a ...

On the occasion of World Immunization Week, the British Embassy in Korea, the British Chamber of Commerce in Korea, and GSK ...

GSK’s blood cancer drug Blenrep won regulatory approval in the U.K., marking the medicine’s return to the market after it was ...

GSK PLC closed 25.31% below its 52-week high of £18.24, which the company reached on May 16th.